GleamWall
中文EN

OFIX Orthofix Medical Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 884624 · Fiscal year ends 12/23

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY2.1%
TTM net income YoY62.2%
TTM EPS YoY63.7%
Revenue 3-yr CAGR7.7%
Net income 3-yr CAGR—

Margins

Gross margin70.9%
Operating margin-2.5%
Net margin-5.4%
FCF margin-5.3%
EBITDA margin3.9%

Returns

ROE-10.3%
ROA-5.3%
ROIC (approx.)-2.9%
Asset turnover0.99x

Leverage & solvency

Liabilities / assets49.8%
Debt / equity0.52x
Current ratio3.11x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.09x
Accruals ratio-5.8%
Payout ratio—
Capex / revenue5.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$822.31M$799.49M$746.64M$460.71M$464.48M
Cost of revenue$256.30M$253.61M$260.37M$123.54M$114.91M
Gross profit$566.02M$545.88M$486.27M$337.17M$349.56M
R&D expense$65.85M$73.64M$80.23M$49.06M$49.62M
SG&A expense$554.33M$532.52M$530.39M$308.78M$69.35M
Operating income-$81.43M-$84.62M-$139.11M-$13.27M-$8.31M
Pretax income-$90.81M-$123.88M-$148.68M-$17.71M-$13.49M
Income tax$1.38M$2.12M$2.72M$2.04M$24.88M
Net income-$92.19M-$126.00M-$151.40M-$19.75M-$38.38M
EBITDA-$4.11M-$24.56M-$86.05M$15.75M$21.28M
EPS (basic)-2.33-3.30-4.12-0.98-1.95
EPS (diluted)-2.33-3.30-4.12-0.98-1.95
Weighted avg. shares (diluted)39.60M38.13M36.73M20.05M19.69M
Banking
Net interest income-$17.49M-$29.63M-$8.63M-$1.29M-$1.84M
Provision for credit losses$2.25M$2.00M$820,000$2.10M$444,000
Balance sheet
Cash & equivalents$82.03M$83.24M$33.11M$50.70M$87.85M
Receivables$135.75M$134.71M$128.10M$82.86M$78.56M
Inventory$172.32M$189.45M$222.17M$100.15M$82.97M
Current assets$416.85M$433.29M$420.44M$255.99M$269.52M
PP&E, net$129.40M$139.80M$159.06M$58.23M$59.25M
Goodwill$194.93M$194.93M$194.93M$71.32M$71.32M
Intangibles$72.77M$98.80M$117.49M$47.39M$52.67M
Total assets$850.65M$893.29M$925.32M$458.63M$476.62M
Current liabilities$170.48M$168.63M$165.22M$83.62M$105.83M
Short-term debt$0$0$1.25M——
Long-term debt$157.39M$157.01M$93.11M——
Total debt$157.39M$157.01M$94.36M——
Total liabilities$400.61M$390.17M$326.58M$121.77M$139.69M
Shareholders' equity$450.04M$503.12M$598.73M$336.86M$336.93M
Net debt$75.37M$73.78M$61.25M——
Shares outstanding39.83M38.49M37.16M20.16M19.84M
Cash flow statement
Operating cash flow$33.35M$25.79M-$45.75M-$11.54M$18.48M
Capital expenditure$34.63M$34.88M$62.05M$23.16M$17.79M
Free cash flow-$1.28M-$9.09M-$107.80M-$34.70M$690,000
Investing cash flow-$34.60M-$27.58M-$33.13M-$24.53M-$23.01M
Financing cash flow-$786,000$50.71M$65.32M-$78,000-$3.62M
Depreciation & amortization$77.32M$60.06M$53.06M$29.02M$29.60M
Stock-based compensation$28.69M$32.45M$35.71M$18.44M$15.43M

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.